Increasing visual field testing frequency enables early glaucoma detection

Article

Increasing visual field testing frequency can lead to the earlier detection of glaucoma.

Increasing visual field testing frequency can lead to the earlier detection of glaucoma, according to a study in the Archives of Ophthalmology.

Dr Kouros Nouri-Mahdavi et al., Glaucoma Division, Jules Stein Eye Institute. University of California, Los Angeles, California, USA, assessed the visual fields of 468 eyes of 381 patients from the Advanced Glaucoma Intervention Study. Patients had 10 or more reliable visual fields and 3 or more follow-up years.

A low-frequency data group was created for every other visual field examination and the original group was maintained as the high-frequency group. A global and point-wise linear regression criterion was used to compare proportion of progressing eyes and time to progression between the two groups.

For the high-frequency data group there was a median of 20 visual field examinations. In the low-frequency data group there was a median number of 12 visual field examinations. There were 204 eyes in the high-frequency data group and 160 in the low-frequency group.

The high-frequency group was more likely to detect glaucoma progression earlier on than the low-frequency group. Point-wise linear regression criteria was more likely to detect improvement in the high-frequency data set.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
© 2025 MJH Life Sciences

All rights reserved.